High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids
暂无分享,去创建一个
D. Sblattero | S. Piazza | D. Mezzanzanica | F. Adorni | C. Santoro | P. Macor | F. Raspagliesi | Y. Ciani | D. Cotella | O. Tarasiuk | C. Deantonio | M. F. Soluri | F. Antony | Yari Ciani | Silvano Piazza
[1] I. Gram,et al. Tumor‐associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation , 2018, International journal of cancer.
[2] R. Kaaks,et al. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection. , 2017, Gynecologic oncology.
[3] P. Bavi,et al. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases. , 2017, Journal of proteomics.
[4] K. Baggerly,et al. Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer , 2017, Clinical Cancer Research.
[5] C. Chapman,et al. Autoantibodies: Opportunities for Early Cancer Detection. , 2017, Trends in cancer.
[6] H. Yoshida,et al. TFE3, HSP47, and CREB3 Pathways of the Mammalian Golgi Stress Response. , 2017, Cell structure and function.
[7] A. Mäkitie,et al. Nanofibrillar cellulose wound dressing in skin graft donor site treatment. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[8] S. Miyano,et al. Whole‐exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia , 2016, British journal of haematology.
[9] R. Bast,et al. Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[10] T. Whiteside,et al. Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma , 2016, Expert review of molecular diagnostics.
[11] Jillian T Henderson,et al. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2016, JAMA.
[12] M. Ziman,et al. Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients. , 2016, Autoimmunity reviews.
[13] T. Okita,et al. Conflicting messages concerning current strategies against research misconduct in Japan: a call for ethical spontaneity , 2016, Journal of Medical Ethics.
[14] M. Hsiao,et al. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition. , 2016, American journal of respiratory and critical care medicine.
[15] J. Ausió,et al. HMGNs: The enhancer charmers , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.
[16] Roland Eils,et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs , 2016, Cell.
[17] M. Montico,et al. Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis , 2015, PloS one.
[18] Jian Huang,et al. Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma. , 2015, World journal of hepatology.
[19] Kaijuan Wang,et al. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis , 2015, Expert review of molecular diagnostics.
[20] H. Brenner,et al. Systematic review: Serum autoantibodies in the early detection of gastric cancer , 2015, International journal of cancer.
[21] R. Sidman,et al. Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer , 2015, Proceedings of the National Academy of Sciences.
[22] Alan Brown,et al. Structure of the large ribosomal subunit from human mitochondria , 2014, Science.
[23] F. Persichetti,et al. An Air-well sparging minifermenter system for high-throughput protein production , 2014, Microbial Cell Factories.
[24] Carlos Enrique Hirales Casillas,et al. Current status of circulating protein biomarkers to aid the early detection of lung cancer , 2014 .
[25] Phillip Stafford,et al. Immunosignature system for diagnosis of cancer , 2014, Proceedings of the National Academy of Sciences.
[26] H. Brenner,et al. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. , 2014, Cancer letters.
[27] E. Diamandis,et al. Deciphering the ovarian cancer ascites fluid peptidome , 2014, Clinical Proteomics.
[28] Akhilesh Pandey,et al. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. , 2013, Biochimica et biophysica acta.
[29] N. Ahmed,et al. Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research , 2013, Front. Oncol..
[30] Flavio Mignone,et al. Profiling celiac disease antibody repertoire. , 2013, Clinical immunology.
[31] Benjamin Haibe-Kains,et al. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome , 2013, Database J. Biol. Databases Curation.
[32] B. Monk,et al. Latest research and treatment of advanced-stage epithelial ovarian cancer , 2013, Nature Reviews Clinical Oncology.
[33] P. Rouanet,et al. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early‐stage breast cancers , 2013, International journal of cancer.
[34] S. Kaye,et al. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research , 2013, Nature Reviews Cancer.
[35] Yong-wen Huang,et al. Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers , 2012, PloS one.
[36] Kaitai Zhang,et al. The ovarian cancer‐derived secretory/releasing proteome: A repertoire of tumor markers , 2012, Proteomics.
[37] N. Heegaard,et al. Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival , 2012, PloS one.
[38] Kenneth P. Nephew,et al. Rethinking ovarian cancer: recommendations for improving outcomes , 2011, Nature Reviews Cancer.
[39] K. Kok,et al. CREB3 subfamily transcription factors are not created equal: Recent insights from global analyses and animal models , 2011, Cell & Bioscience.
[40] P. Hoffmann,et al. Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery , 2011, International journal of molecular sciences.
[41] C. Bokemeyer,et al. Autoantibodies against tumor-related antigens: incidence and biologic significance. , 2010, Human immunology.
[42] Jian-ying Zhang,et al. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors , 2010, Expert review of molecular diagnostics.
[43] N. Halama,et al. Seromic profiling of ovarian and pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.
[44] Luigi Biancone,et al. Rapid interactome profiling by massive sequencing , 2010, Nucleic acids research.
[45] U. Jaeger,et al. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12 , 2009, European journal of clinical investigation.
[46] N. Wentzensen,et al. A systematic review of humoral immune responses against tumor antigens , 2009, Cancer Immunology, Immunotherapy.
[47] E. Diamandis,et al. Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers*S , 2009, Molecular & Cellular Proteomics.
[48] E. Diamandis,et al. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays. , 2009, Clinical biochemistry.
[49] D. Ward,et al. Diagnostic Markers for Early Detection of Ovarian Cancer , 2008, Clinical Cancer Research.
[50] B. Ye,et al. Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients , 2008, Clinical Cancer Research.
[51] Thorsten Verch,et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. , 2008, Gynecologic oncology.
[52] S. Steinberg,et al. Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling , 2006, Clinical Cancer Research.
[53] Gerard Tromp,et al. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. , 2006, Cancer research.
[54] Nuzhat Ahmed,et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer , 2005, Proteomics.
[55] S. Meri,et al. Ascitic complement system in ovarian cancer , 2005, British Journal of Cancer.
[56] Steven J Skates,et al. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] Erkki Ruoslahti,et al. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] X. Estivill,et al. Cloning, Mapping and Expression Analysis of C15 or f4, a Novel Human Gene with Homology to the Yeast Mitochondrial Ribosomal Protein Yml30 Gene , 2001, DNA sequence : the journal of DNA sequencing and mapping.
[59] E. Verdin,et al. BCoR, a novel corepressor involved in BCL-6 repression. , 2000, Genes & development.
[60] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[61] V. Zurawski,et al. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer , 1988, International journal of cancer.
[62] Audrey D. Doerr. Atelier sur la recherche en administration publique au Canada , 1984 .
[63] Carlos Enrique Hirales Casillas,et al. Current status of circulating protein biomarkers to aid the early detection of lung cancer. , 2014, Future oncology.
[64] S. Wotton,et al. Overwinter population estimates of British waterbirds , 2011 .
[65] G. Pruijn,et al. The human exosome and disease. , 2011, Advances in experimental medicine and biology.
[66] M. Chatterjee,et al. Autoantibodies as biomarkers for ovarian cancer. , 2010, Cancer biomarkers : section A of Disease markers.
[67] R. Marzari,et al. Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries. , 2009, Methods in molecular biology.
[68] A. Ignatchenko,et al. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. , 2008, Journal of proteome research.